Purchase Order 75N93023P01267

Award Date 9/12/23
Potential Completion Date 12/31/23
Potential Value $15K
Ultimate Awardee
Revvity Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. for the provision of a "CELLOMETER ASCEND BUNDLE" valued at $17,806.96. The contract has an ultimate completion date of September 10, 2025. Revvity Health Sciences, Inc. is a for-profit manufacturer that provides a variety of medical imaging products and...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. on September 5, 2024. The $17,806.96 contract is for the delivery of a Cellometer Ascend Bundle laboratory instrument, with a period of performance through December 31, 2024. The award does not utilize a small business set-aside. Revvity Health Sciences is a for-profit...
The Department of Health and Human Services' National Institutes of Health awarded a firm fixed-price purchase order worth $176,376.98 to Revvity Health Sciences, Inc. for a Cellaca MX High Throughput-High Speed Cell Counting System and accessories. The contract is to support the National Institute of Allergy and Infectious Diseases (NIAID) and has a period of performance ending on July 30, 2023. There was no set-aside used for this acquisition, which was competed under Simplified Acquisition...
Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a $14,940.06 firm fixed-price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver a CELLOMETER AUTO 2000 BUNDLE (AMBIS #2185560). Performance will occur in Shelton, Connecticut over a six-month period concluding in March 2024. No subcontractors or set-aside designations were indicated. This...
This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency of the U.S. government, to Revvity Health Sciences, Inc. for the delivery of a Revvity Cellometer Ascend Bundle, a type of laboratory equipment. The contract has a ceiling value of $14,988.27 and a period of performance ending on September 2, 2024. The contract was awarded on August 2, 2024 and was not set aside for any specific business type. Revvity Health Sciences is a for-profit...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Revvity Health Sciences, Inc. for the provision of a Cellometer Ascend Bundle (AMBIS #2234455) with a ceiling value of $17,806.96 and a period of performance through January 10, 2025. Revvity Health Sciences is a for-profit manufacturer of medical devices and laboratory equipment that has received multiple...
This is a firm fixed price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. for the delivery of a Cellometer K2 SK Fluorescent Cell Counter Bundle. The contract has a total ceiling value of $18,838.82 and a period of performance through August 26, 2024. Revvity Health Sciences is a for-profit manufacturer that provides a variety of medical imaging products and services to...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. (a subsidiary of Revvity Inc.) for a fundamental service agreement to provide laboratory equipment. The award, valued at $14,865.60, has an ultimate completion date of October 31, 2015. The contract was not set aside for any specific business size or type. Revvity Health Sciences is a for-profit...
This federal contract award to Revvity Health Sciences, Inc. is for the provision of a CELLOMETER medical imaging product to the National Eye Institute, a civilian agency under the National Institutes of Health (NIH). The fixed-price purchase order, valued at $17,806.96, has an ultimate completion date of October 25, 2024. The contract does not have a set-aside designation. Revvity Health Sciences is a for-profit manufacturer of medical devices and equipment that has a history of providing...
This is a $14,309.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Revvity Health Sciences, Inc. on November 27, 2013. The contract was not set aside for any particular business type. The order was placed under the LAW1654271 program and had a period of performance from November 1, 2013 to October 31, 2014, with a final completion date of December 2, 2013. Revvity Health Sciences, Inc. is a subsidiary of the parent company Revvity...

This is a $14,862.05 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Revvity Health Sciences, Inc. The contract is for the delivery of a CELLOMETER AUTO 200 BUNDLE. Revvity Health Sciences, Inc. is a subsidiary of Revvity Inc., a for-profit corporation that provides medical imaging products and services to federal agencies. The contract does not have a set-aside designation. The purchase order will be performed in Bethesda, MD and is scheduled for completion by December 31, 2023.

Generated 10/17/24, 9:18 AM